| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.0066 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |